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The thyroid hormones T4, T3, rT3 and TSH were assayed in 134 adult patients evaluated and 
accepted as potential liver transplant candidates at the Universty of Pittsburgh from March, 1981 
to December, 1983. The subsequent course of these patients was evaluated with respect to the 
levels of these hormones obtained at the time of acceptance for transplantation. T4 levels were 
increased significantly while their T3 levels were reduced (both p < 0.01) in those who survived 
and were discharged home as compared to either those who died waiting to be transplanted or died 
following the procedure. As a result, the ratio of T3/T4 was reduced markedly (p < 0.01) in those 
who were transplanted and survived as compared to those not transplanted or dying following 
transplantation. Importantly, the rT3leveis clearly separated (p < 0.01) those who would die prior 
to transplantation from those who would survive to be transplanted. Finally, the ratio rT3/T3 
even more clearly separates those who will die prior to transplantation (p < 0.01) from the other 
two groups. 
These data suggest that thyroid hormone levels, particularly rT3 levels, might be useful in 
setting priorities for which patients referred for a transplantation evaluation should be accepted 
into the program and in determining who among accepted patients should be operated upon in 
preference to others also accepted and waiting to be transplanted. 
The liwr pla:.'s an important role in maintaining thy· 
roid hormone homeosta5is (1-51. It synthesizes and se· 
cretes the three major th~Droid hormCl~fKbinding proteins 
(lhvT<Jlo- binding globulin or th\'roid-binding prealburnin 
and alhumin i which determine, at lea;;t in nan. the 
pla~mI--; conCt-mrClwn oj fret bi(lJugically aCiKiv~ th~DrElid 
hormone EK~- -;1. In addition. the liver l~ the principal 
or~an re5p(ll1:;ible lor the com'er;;ion of thnoxine or T4 
(a prohormone secreted b\· the thvroid <Tiand, to uiio-
- ~- '=" doth~Dronil1t· or T3 (3"j.:i' -triiodothyronine), the biologi· 
cally active form of thyroid hormone at the level of the 
tissues (2, 3, 81. M051 tis5ues can convert T4 to either 
bll1ogicall~ active T3 or inert rT3 (3,3'.5' -triiodm:hyro· 
nine), however the liver i5 the principal site of T3 pro· 
duction and account" for grealer than 80C.:; of the T3 
produced daily from T4 (2,3,8), 
In many serious systemic illnesses, including advanced 
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chronic liver disea5e. a reduction in plasma T3 levels and 
an increase in rT:3 lewIs occurring in association with a 
normal T4 Je'>el and in the \'irtual absente of any clinical 
e,'jdence for hypothyroidism ha~ been noted (4. 8-lfd. 
qhi~ condition ha~ beer: identified as the low q;~ s~·n­
dr(lme h5- bi(lchi:'nileal Eumponent~ (T:: and rT': leyel~ j 
haw been used to folio\\" the clinical response to medical 
therapy of alcuholico with liver disease and to predict the 
short-term sun'j\'al of patients with ad\'anced chronic 
liver disea5E' (];3-15). 
Until recently, obtaining such data in patient5 with 
ad\"anced liver disease has been valuable only in a nega· 
tive sense in that it accurately predicted the patient's 
demise regardless of the efforts of his physicians to 
prevent such an outcome. \'·ith the recent development 
of orthotopic hepatic transplantation as a clinically use· 
ful therapy. the selection of appropriate patient~ for its 
application has become an issue of considerable concern 
to physicians. surgeons. government and the public 06-
E-li. Because we are in a unique position to offer such 
heroic therapy to patient" with advanced irreyDer~ible 
liYer disease. we prospecti\'ely evaluated. in a double· 
blind fashion, the usefulness of obtaining rneasure~ of 
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lilyroid hormone homeostasis in patients being consid-
ered for this procedure (16, :20). 
MATERIALS AND METHODS 
PATIENTS 
All 134 adult patients being considered for orthotopic 
liver transplantation from March, 1981 through Decem-
ber, 1983 at the Presbyterian-University Hospital, Pitts-
burgh, Pa. had on admission to hospital for their initial 
evaluation, blood obtained after an overnight fast plasma 
levels of T4, T3, rT3 and thyroid-stimulating hormone 
(TSH). The subsequent evaluation for and application 
of orthotopic liver transplantation to these patients pro-
ceeded without knowledge of these results and was based 
primarily upon the clinical experience of the involved 
physicians. 
HORMONE ASSAYS 
Serum TSH was determined by specific radioimmu-
noassay using a kit obtained from Pharmacia Fine Chem-
icals (Piscataway, NJ). The detection limit of the assay 
was l.0 !l U per ml. The intraassay variation was less 
than 5%, and the interassay variation was less than 8%. 
Serum T3 was determined by a specific radioimmunoas-
say using a kit obtained from Corning Medical Diagnos-
tics, Inc. (Medfield, Mass.). The interassay variation was 
less than 7%, and the intraassay variation was less than 
3%. Serum T3 was determined also by a specific radioim-
munoassay using a kit obtained from Corning Medical 
Diagnostics, Inc. The interassay variation for this unit 
was 10%, and its intraassay variation was less than 5%. 
Serum rT3 was determined using a specific radioimmu-
noassay kit obtained from Serono (Braintree, Mass.). 
The interassay variation for this kit was 11%, and its 
intraassay variation was less than 5%. Normal values for 
each hormone assayed were determined using blood 
obtained from 100 consecutive normal volunteer blood 
donors. 
ANALYSIS 
After closing the study on Decell?-ber 31, 1983, the 
values for each hormone obtained at the time of initial 
evaluation for possible liver transplantation were col-
lected and segregated into two groups as follows: Group 
I-those who died waiting to be transplanted (n = 42; 21 
men and 21 women) and Group II-those who underwent 
the procedure (n = 92). This latter group was later 
subdivided into those who died in hospital following 
transplantation (n = 27; 12 men and 15 women) and 
those who survived, and were discharged home (n = 65; 
27 men and 38 women). 
The mean values and the standard errors for each 
hormone assayed were determined for the entire group 
of patients studied and for each subgroup of patients 
identified above. 
Statistical analysis was performed using the Student's 
t test. A p value less than 0.05 was considered to be 
significant. 
Because the collected data were cross-sectional in na-
ture, associations were assessed using the odds ratio as 
an approximation to the relative risk. In this setting, 
thvroid status was considered to be antecedent to the 
ou"tcome (death), thus permitting the odds ratio to be 
used as a measure of risk of experiencing the outcome 
when the antecedent factor was present compared to 
when the antecedent factor was absent. The odds ratio 
is not only an approximation to the relative risk, but the 
use of the logistic model gives rise to the odds ratio as a 
measure of association as welL Using the logarithm (to 
the base e) of the calculated odds ratio and constructing 
a confidence interval (Cn using the standard error of the 
log-odds ratio, permits one to observe whether or not the 
confidence interval of the odds ratio excludes unity [an 
odds ratio of unity (equal to one) indicates no excess 
risk]. WhEm the calculated odds ratio confidence interval 
excludes unity, a x2 test is performed. While the x2 itself 
is not useful as a measure of the degree of an association, 
the x2 is an excellent measure of the significance of an 
association (21). 
RESULTS 
Table 1 is a listing of the patients studied and identi-
fied on the basis of their disease condition for which they 
were being considered as possible or actual candidates 
for liver transplantation. The mean values for TSH, T4, 
T3 and rT3 for the entire group of patients studied are 
shown in Table 2. In Table 3 is shown an estimate of the 
degree of saturation of the thyroid-binding globulin and 
the frequency of various types of autoantibodies present· 
TABLE 1. PATIENTS STUDIED LISTED AS TO DIAGNOSIS AND 
OUTCOME 
Died waiting 
Postnecrotic cirrhosis 
Primary biliary cirrhosis 
Sclerosing cholangitis 
Fulminant type B hepa" 
titis 
HBsAg + postnecrotic 
cirrhosis 
Hepatoma 
Hemochromatosis 
Laennec's cirrhosis 
Wilson's disease 
Secondary biliary cirrho-
sis 
Tyrosenemia 
Total 
Transplanted 
16 Primary biliary cir-
rhosis 
8 Postnecrotic cirrhosis 
3 Sclerosing cholangitis 
2 Hepatoma 
2 ",-antitrypsin 
2 Cholangiolar carci-
noma 
2 HBsAg + postne-
erotic cirrhosis 
2 Caroli' s disease 
2 Secondary biliary cir" 
rhosis 
2 Fulminant hepatic 
failure 
Subacute hepatic fail· 
ure 
42 Wilson's disease 
Multiple hepatic ade· 
noma 
Angiosarcoma 
Budd·Chiari syn-
drorne 
27 
20 
13 
7 
4 
3 
3 
2 
2 
2 
2 
2 
1 
Tyrosinemia 1 
Laennec's cirrhosis 1 
Total 92 
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TABLE 3. Ta UPTAKE AND PRE\ALENCE Of ANTlTHYROGLOBl'LIt>: 
Al\LJ Al\T1MIlROSOMAL Al'TOANTIBODIES IN THE PATIENTS 
Sn:DIEll pbmAoK~qb[l AS TO PRIMARY DISEASE 
mrimar~D biliary cir· 
rhosis (n = 35) 
Primary sclerosing 
cholangi! is 
(n = 16) 
Postnecroti(' cirrho· 
sis (n = 41) 
T3 uptah" 
0.90'::!: 0,06 
0.94 ± 0.10 
1K~T '::!: 0.08' 
Anti! hyroglohulin 
antibod, 
1 (6) 
9 (22) 
a Mean value:!:: S.E.; normal values 0.8-1.2. 
Antimicrosomai 
antibody 
10 (29) 
1 (6) 
9 (22) 
• Number in parentheses = o/c. of total group who were positive for 
antibody. 
'p < 0.01 compared to both primar~ biliary cirrhosis or primary 
sclerosing cholangitis groups. 
in the patients compnsmg the three largest etiologic 
types of liver disease present in the populations studied. 
No difference in TSH levels was noted between the 
various subgroups of patients studied. In contrast, T4, 
T3, rT3 levels and the ratios of T3/T4 and rT3/T3 
clearly distinguished between the various subgroups of 
patienti' studied and defmed according to their outcome. 
In Figure 1 io shown the T4 levels for the three 
subgroupi' of paTients STudied. A'i'. can be seen from the 
figurt' , nCI differencE:' in T4 levels .was noted between 
tho!'-E' who died waiTing to be transplanted and those who 
diE-cl iollylwi!1~ 1 hE- DT()L'edun, In contrast. however. those 
Wh(l ;;.unived had "greater T4 lewis (p < 0.(1) than did 
eit her of the t,'.,o groups of patients who died. \\'hen the 
mean T4 le\'eJ of thE- sUT\'iving group of patients minus 
two St andard deyiat ions for this group is used as an 
arbitrary cut-off value (T4 = 4.8 Ilg per dJ), a T4 level 
<4.8 f.Lg per dl is associated ",:ith a 17.81-foJd increased 
risk (p < O.OO}) of dying: (99S( Cl 102,62, 3.11) (x 2 = 
30.259). 
Despite significantly greater T4 levels, thE' patients 
who ultimately sun·jved had lower T3 levels tp < 0.01·) 
t han did either of the tW() groups who died (Figure 21. As 
wa!" the casE' with the T4 levels, no difference in T31evels 
wa:, noted berween those who died waiting for the pro-
cedUrE' to be performed or those who died following 
performance of the procedure. However, when the T3 
exceeded the mean + 2 S.D. of the survi\'ing group (T3 
= 0.98 ng per mll. the patient had a 6.il·fold increased 
rish Ip < CI.O(l) I of dying as compared to those with a 
lew'] at or heJow thi~ \·alm· (99(:;: ('1 18.43. 2.451 Ex~ == 
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FIG, 1. T4 levels in the patients studied, qh~ ordinate shows the T4 
level, in micrograms per deciliter for thf patienH. studied separated a, 
to OUIcome, Bars represent mean values, and the brackets represent the 
S.E. for each group. The cross· hatched area is the normal range. 
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25.319). The ratio of T3/T 4 levels in the patient s studied 
were even more clearl~D distinguished between the various 
subgroups (FiguTe 3). A'E wa::. the case for the individual 
hormone measurements, no differenCE- in thi~ ratio was 
noted between those who died waiting to have the pro-
cedure and those who died postoperatiyDel~·K In contrast, 
those who survived had lower levels (p < 0.011. However, 
using a T3/T4 ratio of 0.20 as an arbitrary cm-off being 
the mean + 2 S.D, of the sUTyiving group, those patients 
with greater ratios had a 13.56-fold increased risk (p < 
0.0(1) of death as compared to those with values at or 
below U.:::O (99(:( CI = 47.90. 3.84) EA~ = 3S,25cd. 
The rq:~ leveb in thE- patients studied and se1'regated 
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FJ(;. 3. Ratio of T3/T4 in the patients studied. Th!? units along the 
ordinale are microgram;; x 10- I Bars and brackets represent mean 
yDalue~ and S.E .. respectively. 
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T .. :. T:: and T:: iT 4 rat in measures. those who died aft er 
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FIG. 5. Ratio of rT3/T3 in the patient> studied. The ordinate shows 
the ratio in units of picogram~ x 10-3, Bars represent mean values; 
brackets represent S.E. NS. not statistically significant. 
to them (p < 0.01). No statistical difference in rT3 levels 
was found between those who had the procedure and .' . 
survival, and those who had the procedure and died 
(Figure 4). However, a rT3 value greater than 590 pg per 
ml (the mean + 2 S.D. of the surviving group) was 
associated with a 11.02-fold increased risk of death (p < 
0.001) (99% CI = 57.17,213) b: 2 = 18 .. 843) . 
The ratio of rT3/T3 even more clearly distinguished 
between the three subgroups and identified those pa-
tients who would nOl survive to have the procedure 
performed within the time frame of the time required for 
the transplantation evaluation and donor identification 
and matching processes (Figure 5J. Interestingly, those 
whcl died postoperatively had the lowest ratio::. 
DISCUSSlO1\ 
The results of the present study confirm the work of 
previous investigators who haw suggested that the len'ls 
of thyroid hormone measured in blood can be used prog-
nostically in patients with advanced liver diseas€' (12-
15J. Specifically, those patients who were to die prior to 
being tramplanted had greater rT3 levels and greater 
rT;:;.'T:3 ratio;:. than did those who were to survive to have 
,he procedure. 
More importantly, the present data demonstrate sonw .. 
what paradoxically that those patients who will live long 
enough to be evaluated. matched with a donor and sur-
vive the procedure. have greater T4 and lower T3 levels 
and therefore a mueh smaller q~yiq4 ratio than dc. those 
who will die whether their death~ occur before OT after 
the procedure can be performed, The reasons responsiblE' 
for these findin?>' are unclear. In facl. one mighl ha\'e 
exppcted the converse: that is. those with the more se\'en 
livpl disf<1~e and presumab]\ therefore the pooreST ;'U!> 
----------_ ... _-----
866 
vival rates would be expected to have the lowest T3 
level::;, not greater levels. As shown in Table 2, as a group, 
the patients with liver disease had higher TSH levels 
than did the normal controls, albeit levels still well within 
the normal range. Whether this reflects some minor 
degree of thyroid dysfunction associated with the liver 
diseases studied and accounts, at least in part, for the 
findings seems likely. 
These data raise interesting questions about how a 
decision should be made about who should be afforded a 
liver transplant from among a list of potential recipients -
once an acceptable donor organ has been identified. 
Should those patients with the lower. T4 levels and 
greater T3 levels be bypassed in favor of those with 
greater T4 levels and lower T3 levels who would appear 
to have a better chance for survival'? Even more difficult 
is the question: Should those patients with very high rT3 
levels be eliminated from all further consideration be-
cause of their very poor chance of survival'? Conversely, 
should those with very high rT3 levels be the ones we 
preferentially select once they are identified for imme-
diate transplantation because of their very poor prog-
nosis'? Obviously, the present data do not allow us to 
make any such recommendations. However, should our 
findings be replicated by other groups performing liver 
transplantation, considerable thought will have to be 
given to obtaining answers for these rather weighty ques-
tions. 
Similarly, although not a part of the present study, 
one has to wonder if following T3 and rT3 levels during 
the postoperative period would help to identify those 
patients who are having rejection problems and/or rejec-
tion-associated enhanced immunosuppression which can 
lead to the development of an opportunistic infection 
which is the major cause of death one or more weeks 
following successful transplantation. 
Obviously, much more remains to be learned about 
liver transplantation, the selection process and -when 
such surgery should be offered to acceptable candidates 
for the procedure. The present study, however, i~ a 
beginning. The use of laboratory tests which are easily 
performed using radioimmunoassay kits, widely avail-
able, highly reproducible and having a rapid turn around 
time such as T4, T3 and rT3 would appear to be a 
reasonable first step toward improving and fine tuning 
our decision-making processes relative to the application 
of such heroic surgery. 
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